DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

Wells Fargo Maintains Overweight on Principia Biopharma, Raises Price Target to $82

Wells Fargo maintains Principia Biopharma (NASDAQ:PRNB) with a Overweight and raises the price target from $63 to $82.

Benzinga · 02/07/2020 14:02

Wells Fargo maintains Principia Biopharma (NASDAQ:PRNB) with a Overweight and raises the price target from $63 to $82.